Literature DB >> 17727680

Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.

Takuya Sakurai1, Nobuo Kondoh, Massaki Arai, Jun-ichi Hamada, Toshiyuki Yamada, Fumiko Kihara-Negishi, Tetsuya Izawa, Hideki Ohno, Mikio Yamamoto, Tsuneyuki Oikawa.   

Abstract

The Ets family of transcription factors is implicated in malignant transformation and tumor progression, including invasion, metastasis and neo-angiogenesis. In the present study, we found that the Fli-1 gene, a member of the Ets family, was highly expressed in several breast cancer cell lines (MDA-MB231, MDA-MB436, BT-549 and HCC1395). To investigate the functional roles of Fli-1 in breast cancer malignancy, we introduced an expression plasmid containing full-length Fli-1 cDNA into MCF7 breast cancer cells in which endogenous expression of Fli-1 was barely detectable.Overexpression of Fli-1 in MCF7 cells led to inhibition of apoptosis induced by serum depletion or ultraviolet irradiation, although it did not affect cell growth rate in liquid media, colony formation in soft agar or the in vitro invasion capacity of the cells. Expression of Fli-1 and antiapoptotic bcl-2 was coordinately upregulated by serum depletion in MCF7 cells, and the upregulation was inhibited by treatment of the cells with a c-Jun-NH(2)-terminal kinase-specific inhibitor. Furthermore, expression of the bcl-2 gene and protein was enhanced in Fli-1-overexpressing MCF7 cells compared with mock-transfected cells. In addition, human bcl-2 promoter activity was transactivated by Fli-1. These results suggest that Fli-1 contributes to the malignancy of human breast cancer by inhibiting apoptosis through upregulated expression of the bcl-2 gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727680     DOI: 10.1111/j.1349-7006.2007.00598.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  14 in total

1.  Systematic identification of the HSP90 candidate regulated proteome.

Authors:  Zhixiang Wu; Amin Moghaddas Gholami; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2012-02-14       Impact factor: 5.911

2.  Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia.

Authors:  Steven M Kornblau; Yi Hua Qiu; Nianxiang Zhang; Neera Singh; Stefan Faderl; Alessandra Ferrajoli; Heather York; Amina A Qutub; Kevin R Coombes; Dennis K Watson
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

3.  TFmiR: a web server for constructing and analyzing disease-specific transcription factor and miRNA co-regulatory networks.

Authors:  Mohamed Hamed; Christian Spaniol; Maryam Nazarieh; Volkhard Helms
Journal:  Nucleic Acids Res       Date:  2015-05-05       Impact factor: 16.971

4.  Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.

Authors:  Graeme M Birdsey; Nicola H Dryden; Valerie Amsellem; Frank Gebhardt; Kapil Sahnan; Dorian O Haskard; Elisabetta Dejana; Justin C Mason; Anna M Randi
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113

5.  Spi-1, Fli-1 and Fli-3 (miR-17-92) oncogenes contribute to a single oncogenic network controlling cell proliferation in friend erythroleukemia.

Authors:  Samer Kayali; Guillaume Giraud; François Morlé; Boris Guyot
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

6.  FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.

Authors:  Melissa N Scheiber; Patricia M Watson; Tihana Rumboldt; Connor Stanley; Robert C Wilson; Victoria J Findlay; Paul E Anderson; Dennis K Watson
Journal:  Neoplasia       Date:  2014-10-23       Impact factor: 5.715

Review 7.  The ets transcription factor Fli-1 in development, cancer and disease.

Authors:  Y Li; H Luo; T Liu; E Zacksenhaus; Y Ben-David
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

8.  Overexpression of Fli-1 in astrocytoma is associated with poor prognosis.

Authors:  Hung-Pei Tsai; Tai-Hsin Tsai; Ya-Ju Hsieh; Yi-Ting Chen; Chih-Ling Lee; Yi-Cheng Tsai; Ting-Chang She; Chih-Lung Lin; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Oncotarget       Date:  2017-04-25

9.  A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.

Authors:  Tangjingjun Liu; Yao Yao; Gang Zhang; Ye Wang; Bin Deng; Jialei Song; Xiaogang Li; Fei Han; Xiao Xiao; Jue Yang; Lei Xia; You-Jun Li; Maksym Plachynta; Mu Zhang; Chen Yan; Shuzhen Mu; Heng Luo; Eldad Zacksenhaus; Xiaojiang Hao; Yaacov Ben-David
Journal:  Oncotarget       Date:  2017-03-07

10.  Friend leukemia virus integration 1 expression has prognostic significance in nasopharyngeal carcinoma.

Authors:  Xuexia Liang; Dingbo Shi; Jingping Yun; Yanping Mao; Puyun Ouyang; Zhen Su; Jia Fu; Jinghui Hou; Wuguo Deng; Fangyun Xie
Journal:  Transl Oncol       Date:  2014-08       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.